Ashley Gallagher, MA

Pharmacy professionals gather to discuss innovative solutions, fostering collaboration and community engagement at the National Community Pharmacists Association 2025 Convention & Expo.

A study reveals a significant decline in inhaled corticosteroid use among COPD patients, highlighting the need for careful management and monitoring.

A recent study reveals COVID-19 vaccine safety and varying disease activity impacts for systemic lupus erythematosus patients, highlighting important insights for immunization.

The regimen did not show signs of significant hypoglycemia and had a low prevalence of edema despite modest weight gain.

Eli Lilly and Walmart collaborate to enhance access to Zepbound for obesity management, offering direct-to-consumer pricing and nationwide pharmacy pickup.

The approval includes a single and once monthly maintenance injection compared with 2 100 mg/1 mL injections.

Pharmacists redefine their roles as vital health care providers, offering comprehensive patient care and community health advocacy beyond medication dispensing.

Pneumococcal conjugate vaccines significantly reduce pneumonia incidence in children, but safety concerns warrant further investigation in future studies.

Georgia Travlos, PharmD, discusses changes in influenza and respiratory syncytial virus immunizations and coadministration best practices.

A study reveals that lower baseline BMI and early weight loss with liraglutide enhance significant weight loss outcomes in patients with type 2 diabetes.

Patients and physicians favor at-home remdesivir treatment for COVID-19, highlighting satisfaction and confidence in telehealth and nursing support.

PCV21 improved all outcomes for individuals aged 19 to 64 years, including invasive pneumococcal disease, postmeningitis sequelae, and nonbacteremic pneumococcal pneumonia.

Research reveals no significant disparities in cardiovascular disease incidence linked to mental disorders after the COVID-19 pandemic.

Pharmacies evolve with flexible designs and enhanced roles for pharmacists, improving patient care and privacy in community health settings.

Investigators explore how long COVID impacts trust in vaccines, revealing diverse patient experiences and the need for better communication in public health.

Pharmacists can help patients navigate the vast array of OTC options for effective pain relief, fever reduction, and targeted symptom management.

Tezspire gains FDA approval as the first biologic for chronic rhinosinusitis with nasal polyps, offering improved patient outcomes.

Pharmacists enhance patient care through automation, blood pressure monitoring, and community health services, improving accessibility and reducing burnout.

FDA approves oral semaglutide for reducing cardiovascular risks in high-risk type 2 diabetes patients, enhancing treatment options and outcomes.

A recent study reveals a heightened stroke risk in asthma patients recovering from severe COVID-19, emphasizing the need for proactive monitoring and management.

The FDA expands Yuflyma's approval to treat hidradenitis suppurativa and uveitis in pediatric patients, enhancing treatment options for chronic conditions.

Orforglipron demonstrates superior glycemic control in phase 3 trials, showing promise as a new treatment for type 2 diabetes.

The FDA approves the Insti HIV Self Test, enabling rapid, accurate results in just one minute, enhancing access to HIV testing nationwide.

A study shows young adults with 3 or more COVID-19 vaccine doses experience fewer symptoms, emphasizing vaccination's critical role in public health.

As misinformation persists, health experts and research point to pharmacists as key communicators in building trust and boosting immunization rates.

CVS Pharmacy acquires Rite Aid assets in the Pacific Northwest, enhancing pharmacy access while addressing the growing crisis of pharmacy closures nationwide.

The biosimilar is also approved for indications of Eylea, including neovascular age-related macular degeneration, macular edema following retinal vein occlusion, and diabetic retinopathy.

The FDA approves Uzedy, a long-acting risperidone injection, enhancing treatment options for adults with bipolar I disorder and addressing unmet needs.

Pharmacists navigate financial challenges and evolving roles, requiring communication and problem-solving skills amid technological advancements.